These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8067837)

  • 1. Risk and benefit of low systemic heparinization during open heart operations.
    von Segesser LK; Weiss BM; Pasic M; Garcia E; Turina MI
    Ann Thorac Surg; 1994 Aug; 58(2):391-7; discussion 398. PubMed ID: 8067837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization.
    von Segesser LK; Weiss BM; Garcia E; Gallino A; Turina M
    Eur J Cardiothorac Surg; 1990; 4(12):639-43. PubMed ID: 2288743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction and elimination of systemic heparinization during cardiopulmonary bypass.
    von Segesser LK; Weiss BM; Garcia E; von Felten A; Turina MI
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):790-8; discussion 798-9. PubMed ID: 1548923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved distal circulatory support for repair of descending thoracic aortic aneurysms.
    von Segesser LK; Killer I; Jenni R; Lutz U; Turina MI
    Ann Thorac Surg; 1993 Dec; 56(6):1373-80. PubMed ID: 8267439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
    von Segesser LK; Turina M
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits.
    Ranucci M; Cazzaniga A; Soro G; Isgrò G; Frigiola A; Menicanti L
    J Cardiothorac Vasc Anesth; 2002 Jun; 16(3):316-20. PubMed ID: 12073203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
    von Segesser LK; Garcia E; Turina MI
    Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M
    Circulation; 1995 Nov; 92(9):2579-84. PubMed ID: 7586360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study.
    Aldea GS; Doursounian M; O'Gara P; Treanor P; Shapira OM; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1996 Aug; 62(2):410-7; discussion 417-8. PubMed ID: 8694599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-coated circuit during cardiopulmonary bypass. A clinical study using closed circuit, centrifugal pump and reduced heparinization.
    Sellevold OF; Berg TM; Rein KA; Levang OW; Iversen OJ; Bergh K
    Acta Anaesthesiol Scand; 1994 May; 38(4):372-9. PubMed ID: 8067226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term cardiopulmonary bypass without systemic heparinization.
    von Segesser K; Turina M
    Int J Artif Organs; 1990 Oct; 13(10):687-91. PubMed ID: 2254046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.